Author: Voskoboynik Berenika
Publisher: Springer Publishing Company
ISSN: 1556-9039
Source: Journal of Medical Toxicology, Vol.7, Iss.1, 2011-03, pp. : 57-59
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Cevimeline (Evoxac ®) is an oral muscarinic agent that has been recently approved for the treatment of xerostomia in the setting of Sjogren's syndrome. Its toxicity in overdose has not been reported in the medical literature to date. We report a previously healthy patient who intentionally ingested approximately 10 mg/kg of cevimeline and presented with symptoms of muscarinic excess and mental status depression. The patient recovered uneventfully after receiving activated charcoal and supportive care. This report describes the first documented cevimeline overdose.
Related content
By Weber Juliane Keating Gillian M.
Drugs, Vol. 68, Iss. 12, 2008-01 ,pp. :
Cevimeline overdose: Diaphoresis, nausea, vomiting and somnolence: case report
Reactions Weekly, Vol. 1, Iss. 1328, 2010-01 ,pp. :
Cevimeline provides substantial relief of xerostomia symptoms
Inpharma, Vol. 1, Iss. 1347, 2002-01 ,pp. :
Pharmacoeconomics of Antidepressant Drug Overdose
By Palmer C.S.
CNS Drugs, Vol. 10, Iss. 3, 1998-09 ,pp. :
Cisplatin Overdose: Toxicities and Management
By Tsang Roger Y. Al-Fayea Turki Au Heather-Jane
Drug Safety, Vol. 32, Iss. 12, 2009-12 ,pp. :